TWI370735B - Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome - Google Patents
Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndromeInfo
- Publication number
- TWI370735B TWI370735B TW096144583A TW96144583A TWI370735B TW I370735 B TWI370735 B TW I370735B TW 096144583 A TW096144583 A TW 096144583A TW 96144583 A TW96144583 A TW 96144583A TW I370735 B TWI370735 B TW I370735B
- Authority
- TW
- Taiwan
- Prior art keywords
- agomelatine
- smith
- treatment
- magenis syndrome
- medicaments intended
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Primary Cells (AREA)
- Connection Of Batteries Or Terminals (AREA)
- General Preparation And Processing Of Foods (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0610296A FR2908995B1 (fr) | 2006-11-24 | 2006-11-24 | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du syndrome de smith magenis |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200829237A TW200829237A (en) | 2008-07-16 |
TWI370735B true TWI370735B (en) | 2012-08-21 |
Family
ID=38229648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW096144583A TWI370735B (en) | 2006-11-24 | 2007-11-23 | Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome |
Country Status (38)
Country | Link |
---|---|
US (1) | US20080132577A1 (zh) |
EP (1) | EP1929999B1 (zh) |
JP (1) | JP2008127395A (zh) |
KR (2) | KR20080047299A (zh) |
CN (1) | CN101194901A (zh) |
AR (1) | AR063896A1 (zh) |
AT (1) | ATE501717T1 (zh) |
AU (1) | AU2007234614B2 (zh) |
BR (1) | BRPI0704453A2 (zh) |
CA (1) | CA2610638C (zh) |
CL (1) | CL2007003396A1 (zh) |
CY (1) | CY1111430T1 (zh) |
DE (1) | DE602007013166D1 (zh) |
DK (1) | DK1929999T3 (zh) |
EA (1) | EA013471B1 (zh) |
ES (1) | ES2363252T3 (zh) |
FR (1) | FR2908995B1 (zh) |
GE (1) | GEP20094746B (zh) |
HR (1) | HRP20110370T1 (zh) |
JO (1) | JO2656B1 (zh) |
MA (1) | MA29523B1 (zh) |
ME (1) | ME01959B (zh) |
MX (1) | MX2007014199A (zh) |
MY (1) | MY145139A (zh) |
NO (1) | NO338951B1 (zh) |
NZ (1) | NZ563684A (zh) |
PE (1) | PE20081347A1 (zh) |
PL (1) | PL1929999T3 (zh) |
PT (1) | PT1929999E (zh) |
RS (1) | RS51676B (zh) |
SA (1) | SA07280635B1 (zh) |
SG (1) | SG143203A1 (zh) |
SI (1) | SI1929999T1 (zh) |
TW (1) | TWI370735B (zh) |
UA (1) | UA94042C2 (zh) |
UY (1) | UY30704A1 (zh) |
WO (1) | WO2008071870A2 (zh) |
ZA (1) | ZA200710103B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH12012000132A1 (en) * | 2011-06-09 | 2014-10-20 | Servier Lab | New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them |
FR2978916B1 (fr) * | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
ES2645223T3 (es) | 2013-06-06 | 2017-12-04 | Zentiva, K.S. | Formulaciones de agomelatina que comprenden agomelatina en forma de co-cristales |
EP2810647A1 (en) * | 2013-06-06 | 2014-12-10 | Zentiva, a.s. | Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1564202A (en) * | 1924-05-20 | 1925-12-08 | Christensen Jens Herman | Method of producing water-insoluble multicolored screens |
FR2658818B1 (fr) | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2866335B1 (fr) * | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
-
2006
- 2006-11-24 FR FR0610296A patent/FR2908995B1/fr not_active Expired - Fee Related
-
2007
- 2007-01-01 ZA ZA200710103A patent/ZA200710103B/en unknown
- 2007-11-07 PE PE2007001528A patent/PE20081347A1/es not_active Application Discontinuation
- 2007-11-08 UY UY30704A patent/UY30704A1/es not_active Application Discontinuation
- 2007-11-13 MX MX2007014199A patent/MX2007014199A/es active IP Right Grant
- 2007-11-13 MY MYPI20071976A patent/MY145139A/en unknown
- 2007-11-19 MA MA30379A patent/MA29523B1/fr unknown
- 2007-11-21 US US11/986,501 patent/US20080132577A1/en not_active Abandoned
- 2007-11-22 CL CL200703396A patent/CL2007003396A1/es unknown
- 2007-11-22 GE GEAP200710391A patent/GEP20094746B/en unknown
- 2007-11-22 AR ARP070105184A patent/AR063896A1/es unknown
- 2007-11-22 JP JP2007302457A patent/JP2008127395A/ja active Pending
- 2007-11-22 JO JO2007487A patent/JO2656B1/en active
- 2007-11-22 AU AU2007234614A patent/AU2007234614B2/en not_active Ceased
- 2007-11-23 PT PT07291391T patent/PT1929999E/pt unknown
- 2007-11-23 UA UAA200713021A patent/UA94042C2/ru unknown
- 2007-11-23 PL PL07291391T patent/PL1929999T3/pl unknown
- 2007-11-23 AT AT07291391T patent/ATE501717T1/de active
- 2007-11-23 DE DE602007013166T patent/DE602007013166D1/de active Active
- 2007-11-23 CN CNA2007103061420A patent/CN101194901A/zh active Pending
- 2007-11-23 ES ES07291391T patent/ES2363252T3/es active Active
- 2007-11-23 ME MEP-2011-219A patent/ME01959B/me unknown
- 2007-11-23 EA EA200702318A patent/EA013471B1/ru not_active IP Right Cessation
- 2007-11-23 NO NO20075989A patent/NO338951B1/no not_active IP Right Cessation
- 2007-11-23 SI SI200730595T patent/SI1929999T1/sl unknown
- 2007-11-23 RS RS20110157A patent/RS51676B/en unknown
- 2007-11-23 SG SG200718042-5A patent/SG143203A1/en unknown
- 2007-11-23 NZ NZ563684A patent/NZ563684A/en not_active IP Right Cessation
- 2007-11-23 TW TW096144583A patent/TWI370735B/zh not_active IP Right Cessation
- 2007-11-23 KR KR1020070120251A patent/KR20080047299A/ko not_active Application Discontinuation
- 2007-11-23 CA CA2610638A patent/CA2610638C/fr not_active Expired - Fee Related
- 2007-11-23 WO PCT/FR2007/001926 patent/WO2008071870A2/fr active Application Filing
- 2007-11-23 DK DK07291391.6T patent/DK1929999T3/da active
- 2007-11-23 EP EP07291391A patent/EP1929999B1/fr active Active
- 2007-11-23 BR BRPI0704453-4A patent/BRPI0704453A2/pt not_active Application Discontinuation
- 2007-11-24 SA SA07280635A patent/SA07280635B1/ar unknown
-
2011
- 2011-04-27 CY CY20111100416T patent/CY1111430T1/el unknown
- 2011-05-18 HR HR20110370T patent/HRP20110370T1/hr unknown
- 2011-07-06 KR KR1020110066825A patent/KR20110086673A/ko not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2453188B (en) | Use of compounds in the manufacture of medicaments for treatment of regional fat deposits | |
ZA200808409B (en) | Use of rasagiline for the treatment of restless legs syndrome | |
EP1971278A4 (en) | PROCESS FOR SURFACE TREATMENT OF THE SKIN | |
PL1978947T3 (pl) | Nitrooksypochodne do zastosowania w leczeniu dystrofii mięśniowych | |
AP2965A (en) | Therapeutic compositions and the use thereof | |
LT2068889T (lt) | Anakinra, naudojama bronchiolito obliteranso sindromo gydymui | |
AP2490A (en) | Therapeutic compositions and the use thereof | |
PL2205273T3 (pl) | Zastosowanie zmodyfikowanych komórek w leczeniu stwardnienia rozsianego | |
AP2488A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder | |
HUE037109T2 (hu) | Endoxifén rák kezelésében történõ alkalmazásra | |
AP2008004379A0 (en) | Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorder in the depressed patient | |
HK1203160A1 (zh) | 治療關節炎疼痛的他噴他多 | |
EP1982724A4 (en) | THERAPEUTIC AGENT FOR THE TREATMENT OF METABOLIC SYNDROME AND FOODS CONTAINING THE SAME | |
IL212672A (en) | Cycloandesdepsipeptide compounds and their use in drug production | |
TWI370735B (en) | Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome | |
TWI318115B (en) | Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders | |
GB0710277D0 (en) | Use of antivirals in the treatment of medical disorders | |
EP2231163A4 (en) | COMPOUNDS AND THEIR THERAPEUTIC USE | |
HK1125634A1 (en) | Pharmaceutical for use in the treatment of ureterolithiasis | |
IL182406A0 (en) | Use of an anti-atherothrombotic compound in obtaining medicaments intended for the treatment of vascular disorders | |
ZA201000469B (en) | Therapeutic compositions and the use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |